Tonix Pharmaceuticals Holding (TNXP) Asset Utilization Ratio (2023 - 2026)

Tonix Pharmaceuticals Holding has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.11 in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 119.84% year-over-year to 0.11 in Q2 2026; TTM through Jun 2026 was 0.11, a 119.84% increase from a year earlier, with the FY2025 full-year figure at 0.06, down 6.36% from the prior year.
• Asset Utilization Ratio was 0.11 for Q2 2026 at Tonix Pharmaceuticals Holding, up from 0.07 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.14 in Q3 2024, with the low at 0.05 in Q3 2025.
• Average Asset Utilization Ratio over 4 years is 0.09, with a median of 0.09 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio slumped 65.72% in 2025, then surged 119.84% in 2026.
• Over 4 years, Asset Utilization Ratio stood at 0.1 in 2023, then fell by 23.08% to 0.08 in 2024, then sank by 36.77% to 0.05 in 2025, then surged by 129.67% to 0.11 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.11 (Q2 2026), 0.07 (Q1 2026), and 0.05 (Q4 2025), per Business Quant data.